LVMH has offered to buy Tiffany & Co, known for its engagement rings and ties to Hollywood glamor, as the owner of Louis Vuitton and Bulgari seeks to expand in jewelry, one of the fastest-growing parts of the luxury goods market.
Average Americans are still struggling to regain what they lost during the recession, while the top 1% have gotten even wealthier.
Today, Alexander Green explains what the rich are doing differently and how others can catch up.
The Wall Street Journal recently ran an interesting article under the headline “Historic Asset Boom Passes by Half of Families.”
It pointed out that the economic expansion of the last decade has created staggering new wealth – and a record number of millionaire households – but that roughly half of Americans have been left behind.
According to new figures released by the Federal Reserve, the bottom half …read more […]
The U.S. goods trade deficit fell in September as trade tensions restricted the flow of goods, but that did not change views that economic growth decelerated further in the third quarter amid slowing consumer spending and declining business investment.
An index of global stock markets rose to a 21-month high on Monday, boosted by growing hopes for a U.S.-China trade deal and the view that the U.S. Federal Reserve this week will deliver its third interest rate cut for 2019.
We at Insider Monkey have gone over 730 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds’ and investors’ portfolio positions as of June 28th. In this article, we look at what those funds think of Aimmune Therapeutics Inc (NASDAQ:AIMT) based on that […] …read more […]
World-class money managers like Ken Griffin and Barry Rosenstein only invest their wealthy clients’ money after undertaking a rigorous examination of any potential stock. They are particularly successful in this regard when it comes to small-cap stocks, which their peerless research gives them a big information advantage on when it comes to judging their worth. […] …read more […]
Microsoft beat out Amazon for a $10 billion Department of Defense contract.
The 10-year JEDI contract is for the Pentagon’s cloud services and it’s a big win for Microsoft Azure as a competitor to AWS. Yahoo Finance’s Dan Roberts, Julia La Roche and Brian Cheung discuss on YFi AM. …read more […]
Reputable billionaire investors such as Jim Simons, Cliff Asness and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required to invest in a hedge fund and most successful hedge funds won’t accept your savings unless you commit at least $5 million) by pinpointing […] …read more […]
Spotify Technology SA posted a surprise profit and beat Wall Street expectations for third-quarter revenue as the music streaming company added more-than-expected subscribers to its premium service, sending its shares up 12%.
Today we’ll look at HNI Corporation (NYSE:HNI) and reflect on its potential as an investment. Specifically, we’re… …read more […]
AT&T Inc on Monday unveiled a three-year strategic plan that included adding two new board members, selling off up to $10 billion worth of non-core businesses next year and paying off all its debt from the purchase of Time Warner, bowing to pressure from activist investor Elliott Management.
The head of the U.S. Federal Aviation Administration (FAA) on Monday made a broad appeal for the airline industry to focus on safety, one day before the first anniversary of a deadly crash involving Lion Air and a Boeing 737 MAX plane that cost hundreds of lives.
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 45% and 39% respectively. Hedge funds’ top 3 stock picks returned 34.4% this year and beat the S&P […] …read more […]
Allergan Plc would pay $750 million to settle a class action lawsuit from a group of direct purchasers of Alzheimer’s disease therapy Namenda, the drugmaker said, in a resolution to the litigation that was set to face trial on Monday. The lawsuit alleged that Allergan’s Forest units worked to delay generic competition for Namenda, including entering an illegal agreement with its competitor Mylan NV. Forest, the original maker of Namenda, discontinued the tablets taken twice daily in February 2014 and replaced it with a version taken once daily before the launch of a generic version in July 2015. …read more […]
The benchmark S&P 500 index hit a record high on Monday as a possible trade deal between the U.S. and China, and rising bets on a third rate cut by the Federal Reserve, bolstered investor optimism.
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
